Biomedical (ADVANCED)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272200800055C
- Awardee
-
Integrated Biotherapeutics, LLC UEI XNTHMSN2JJP5
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,985,238
Award facts
- Opportunity
-
- Advanced Development of Multivalent Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines Award Notice · Posted Sep 4, 2007
- Contract value 25% obligated
-
- $14,985,238.21 Current, with exercised options
- $59,056,917.21 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Germantown, MD 20876, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,391,173 | |
| Other Administrative Action | -$600,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$564,667 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$1,667,930 | |
| Exercise an Option | $9,210,189 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $6,180,074 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $5,818,745 |
Show all 13
About this award
This is a federal contract award from the National Institutes of Health (NIH) to Integrated Biotherapeutics, LLC (doing business as IBT Bio Services), a self-certified small disadvantaged business. The $59,056,917.21 cost-plus-fixed-fee contract is for biomedical research and services, with a period of performance through July 2, 2014. IBT Bio Services has provided animal testing services to evaluate vaccine candidates and monoclonal antibodies for diseases such as COVID-19, neuroblastoma, Marburg virus, and Staphylococcus aureus infections. The contract is not set-aside. IBT Bio Services has also received past prime and subcontract awards, as well as grants, from NIH and other agencies for related biomedical research and development efforts.
Quick answers
Who was awarded contract HHSN272200800055C?
HHSN272200800055C was awarded to Integrated Biotherapeutics, LLC by NIAID DEA OA Acquisitions (National Institutes of Health) on September 30, 2008.
How much is contract HHSN272200800055C worth?
The government has obligated $14,985,238 on HHSN272200800055C. Its potential value, with all options, is $59,056,917.
Was contract HHSN272200800055C competed?
The extent of competition for HHSN272200800055C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award